Validation of surrogate endpoints involves rigorous statistical analysis to ensure they accurately predict the clinical outcomes of interest. This process includes:
Correlation Studies: Checking the correlation between the surrogate endpoint and the clinical outcome. Meta-Analyses: Aggregating data from multiple studies to assess the reliability of the surrogate endpoint. Regulatory Review: Regulatory bodies like the FDA evaluate the surrogate endpoints to ensure they meet the required standards.
